Evidence map›Paper›PMID 25965334›Full record

ArticlePLoS pathogens2015

A ribonucleoprotein complex protects the interleukin-6 mRNA from degradation by distinct herpesviral endonucleases.

Mandy Muller, Stephanie Hutin, Oliver Marigold, Kathy H Li, Al Burlingame, Britt A Glaunsinger

Open access · goldAbstract readComparative Study
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. The mProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mandy MullerDepartment of Plant and Microbial Biology, University of California, Berkeley, Berkeley, California, United States of America.
Stephanie HutinDepartment of Plant and Microbial Biology, University of California, Berkeley, Berkeley, California, United States of America.
Oliver MarigoldDepartment of Plant and Microbial Biology, University of California, Berkeley, Berkeley, California, United States of America.
Kathy H LiDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, United States of America.
Al BurlingameDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, United States of America.
Britt A GlaunsingerDepartment of Plant and Microbial Biology, University of California, Berkeley, Berkeley, California, United States of America; Department of Cell and Molecular Biology, University of California, Berkeley, Berkeley, California, United States of America.
University of California, Berkeley · USUniversity of California, San Francisco · US

Funding

Bio-Organic Biomedical Mass Spectromy ResourceP41GM103481 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BURLINGAME, ALMA L · 2012 to 2015
$6.4M
Disruption of Cellular RNA Processing by Kaposi's Sarcoma-Associated HerpesvirusR01CA136367 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI Britt A Glaunsinger · 2010 to 2026
$5.8M
Escape from gammaherpesvirus-induced mRNA destructionR01CA160556 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI GLAUNSINGER, BRITT A · 2011 to 2015
$1.5M
Howard Hughes Medical InstituteNCI NIH HHS CA136367NCI NIH HHS CA160556NCI NIH HHS R01 CA136367NCI NIH HHS R01 CA160556NIGMS NIH HHS 8P41GM103481NIGMS NIH HHS P41 GM103481
6 · The paper itself

Abstract

During lytic Kaposi's sarcoma-associated herpesvirus (KSHV) infection, the viral endonuclease SOX promotes widespread degradation of cytoplasmic messenger RNA (mRNA). However, select mRNAs escape SOX-induced cleavage and remain robustly expressed. Prominent among these is interleukin-6 (IL-6), a growth factor important for survival of KSHV infected B cells. IL-6 escape is notable because it contains a sequence within its 3' untranslated region (UTR) that can confer protection when transferred to a SOX-targeted mRNA, and thus overrides the endonuclease targeting mechanism. Here, we pursued how this protective RNA element functions to maintain mRNA stability. Using affinity purification and mass spectrometry, we identified a set of proteins that associate specifically with the protective element. Although multiple proteins contributed to the escape mechanism, depletion of nucleolin (NCL) most severely impacted protection. NCL was re-localized out of the nucleolus during lytic KSHV infection, and its presence in the cytoplasm was required for protection. After loading onto the IL-6 3' UTR, NCL differentially bound to the translation initiation factor eIF4H. Disrupting this interaction, or depleting eIF4H, reinstated SOX targeting of the RNA, suggesting that interactions between proteins bound to distant regions of the mRNA are important for escape. Finally, we found that the IL-6 3' UTR was also protected against mRNA degradation by the vhs endonuclease encoded by herpes simplex virus, despite the fact that its mechanism of mRNA targeting is distinct from SOX. These findings highlight how a multitude of RNA-protein interactions can impact endonuclease targeting, and identify new features underlying the regulation of the IL-6 mRNA.

Indexed as

RNA Stability3' Untranslated RegionsB-LymphocytesCell Line, TransformedEndonucleasesGenes, ReporterHalf-LifeHEK293 CellsHerpesviridae InfectionsHerpesvirus 8, HumanHumansHydrolysisInterleukin-6NucleolinPhosphoproteinsProtein Transport3' Untranslated RegionsEndonucleasesIL6 protein, humanInterleukin-6NucleolinPhosphoproteinsRecombinant Fusion ProteinsRibonucleoproteinsRNARNA-Binding ProteinsRNA, MessengerRNA, recombinantViral Proteins

Identifiers

PMID25965334
PMCPMC4428876
OpenAlexW307821344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.